Dexcom (DXCM) Long-Term Debt Issuances (2017 - 2018)

Dexcom (DXCM) reported Long-Term Debt Issuances of $836.6 million for Q4 2018, up 166.43% year-over-year from $314.0 million in Q4 2017, and up 166.43% quarter-over-quarter from $314.0 million in Q4 2017.

Dexcom (DXCM) Long-Term Debt Issuances (2017 - 2018) Analysis & Trends

Dexcom (DXCM) has 2 years of Long-Term Debt Issuances data on file, last reported at $836.6 million in Q4 2018.

  • Long-Term Debt Issuances for Q4 2018 came in at $836.6 million, up 166.43% year-over-year; the trailing twelve-month figure through Sep 2020 was $836.6 million (changed 0.0% YoY), and the FY2023 annual result was $1.2 billion, changed N/A from the prior year.
  • Long-Term Debt Issuances advanced to $836.6 million in Q4 2018 per DXCM's latest filing, from $314.0 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $836.6 million in Q4 2018 and troughed at $75.0 million in Q1 2017.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 19.86 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 1.15 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2018 836.60 Mn
Dec 31, 2018 836.60 Mn
Dec 31, 2017 314.00 Mn
Dec 31, 2017 314.00 Mn
Sep 30, 2017 389.00 Mn
Sep 30, 2017 389.00 Mn
Jun 30, 2017 389.00 Mn
Jun 30, 2017 389.00 Mn
Mar 31, 2017 75.00 Mn
Mar 31, 2017 75.00 Mn